A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

NCT00133185 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: telmisartan 40 mg/hydrochlorothiazide 12.5 mg
DRUG: losartan 50 mg/hydrochlorothiazide 12.5 mg

Sponsor

Boehringer Ingelheim